The interaction between mouse choriomammotropin and mouse mammary glands was examined by radioreceptor assays using ovine prolactin (NIH-P-S9) iodinated by lactoperoxidase as a tracer. Mouse pituitary extracts and placental extracts were subjected to 10% acrylamide gel electrophoresis.
Mouse choriomammotropin
has been studied by a number of authors (Newton and Beck, 1939; Cerruti and Lyons, 1960; Kirby, 1965; Kohmoto and Bern, 1970; Yanai and Nagasawa, 1971) . Kohmoto (1975) reported that two lactogenic proteins were synthesized by mouse placentae in organ culture.
It is uncertain, however, whether one of the hormones was derived from the other, or whether they were synthesized as different proteins. The presence of two choriomammotropins has also been reported in several other mammalian species (man: Suwa and Friesen, 1969 ; rhesus monkeys: Shome and Friesen, 1971; rats: Kelly et al., 1975) . The physiological meaning of the presence of two components of choriomammotropin is still unclear in any of these animals.
Recent studies have shown that lactogenic hormones, such as ovine prolactin, human somatotropin and human choriomammotropin, interact with the specific receptor site for prolactin (Shiu et al., 1973; Frantz et al., 1974; Sakai et al., 1975) . This study was undertaken to determine whether both components of mouse choriomammotropin interact with the receptor site for pituitary prolactin in th mammary gland. In this paper, we used the radioreceptor assay of prolactin established by Sakai et al.(1975 
Results
Lactogenic hormones in placentae and in pituitaries competed with 1251-prolactin at the receptor site for prolactin in mouse mammary glands as examined by radioreceptor assays after electrophoresis on 10% acrylamide gel (Fig.1) . In pituitaries (Fig.  la) , displacement of 125I-prolactin was seen only at the same position as the prolactin band (Rm 0.53) on a stained gel. No displacement was seen at the position which represents albumin (Rm 0.48) and mouse somatotropin (Rm 0.26). A slight displacement of 125I-prolactin occurred at Rm 0.86 in one experiment, but not in two other experiments. Displacement was observed at two positions on 10% gels (Rm 0.21 and 0.71) in placentae (Fg. 1b).
More 125I-prolactin was displaced at Rm 0.21 than at 0.71. Neither of them was visible as a stained protein band. Shiu and Friesen (1975) and Sakai et al. was present in the mammary gland and that only lactogenic hormones, such as ovine prolactin, human somatotropin and human choriomammotropin, bound to this receptor site as the first step of a chain of hormone action.
Radioreceptor assays are now widely used and the interaction between prolactin receptors of the rabbit mammary particulate fraction and choriomammotropin from man, rats and sheep was reported Chan et al., 1976) . However, the interaction between choriomammotropin and the mouse mammary gland had not yet been investigated. It is shown in this study that mouse choriomammotropin displaces iodinated ovine prolactin, similar to prolactin and choriomammotropin from other species.
Several authors reported that the mouse placenta stimulates the mammary gland (Newton and Beck, 1939; Cerruti and Lyons, 1960; Kirby, 1965; Yanai and Nagasawa, 1971 ) and the ovary (Zeilmaker, 1968) . A direct mammotropic effect of the mouse placenta was demonstrated by Kohmoto and Bern (1970) by means of organ co-culture of midpregnant mouse mammary tissues with placental explants from various stages of pregnany. The existence of two components of choriomammotropin in mice was reported by Kohmoto The log (Rm) on gel concentration (100%) versus molecular weight was plotted using myoglobin, chymotrypsinogen A, ovalbumin and bovine serum albumin as standard materials.
The open circle represents ovine prolactin, mouse prolactin and mouse choriomammotropin.
(1975), who separated these proteins on 7 acrylamide gel electrophoresis. The slowly migrating component of choriomammotropin in the present study (Rm 0.21 on 10 gel) corresponds to band 4 (Rm 0.33 on 7% gel) from the calculated mobility on 7% gel. The rapidly migrating component (Rm 0.71 on 10% gel) was not exactly identified as band 1 (Rm 0.85 on 7% gel) separated by Kohmoto (1975) because its molecular weight was not estimated due to insufficient amounts present in the placenta. However, the rapidly migrating component probably represents band 1 in the former paper because we did not detect any other corresponding component than the rapidly migrating choriomammotropin.
The parallelism of the dose-response curves between ovine prolactin and dilutions of the placental extracts suggested that mouse choriomammotropin bound to the same receptor site Vol.23, No.6 MOUSE CHORIOMAMMOTROPIN as did ovine prolactin. The presence of two components of choriomammotropin could be explained in several ways: 1) one is an aggregate of the other, 2) one is degraded protein of the other, or 3) they are different proteins from the biginning. It is not likely that one is an aggregate of the other, because the major component which has a molecular weight of 23000, similar to choriomammotropin from other species (man: Friesen, 1965, and Li et al., 1970; rats: Robertson and Friesen, 1975; sheep: Martel and Djiane, 1975, and Chan et al., 1976) and thought to be a monomer, migrates more slowly (Rm 0.21 on 10% gel) than the minor component (Rm 0.71 on 10% gel). Aggregated proteins usually migrate more slowly than monomer proteins. The rapidly migrating component is assumed to be largely degraded, if it is a product of degradation, because its mobility has changed a great deal. It would be unlikely that the minor component still has lactogenic activity after such degradation. Therefore, the two components of mouse choriomammotropin are probably synthesized as different proteins. However, it remains still unclear whether both of the components play the same or different roles.
